Search

everythinglearnresearchcommunity

for

Search:↓

Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.

Diagnosing diffuse alopecia, a hair loss condition, can be challenging and may require a scalp biopsy or tracking the disease's progression when symptoms and skin tests aren't enough.

New treatments are available for managing ingrown hair inflammation.

Hair loss in adult females in Makkah is often linked to iron-deficiency anemia and thyroid issues.

Poor sleep during the pandemic may increase stress and worsen hair loss conditions.

Wound tension after hair transplant surgery increases with strip size and is higher on the sides, affecting scarring.

A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Platelet-rich fibrin might be a promising treatment for hair loss, but more research is needed to confirm its effectiveness.

The study concluded that the developed models are effective for studying hair growth mechanisms and testing new treatments.

Telogen effluvium is a common, distressing condition causing excessive hair shedding and has significant psychological effects on patients.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

Different botulinum toxin products and concentrations can effectively reduce sweating, itching, bladder pressure, hair loss, and muscle spasms.

Iron deficiency may contribute to chronic hair loss in premenopausal women.

AGA and TE can be differentiated by specific trichoscopic features, with AGA showing more variation in hair thickness in fronto-temporal areas.

Cyclosporine A slows down hair loss from chemotherapy in mice, while dexamethasone increases hair loss but speeds up regrowth.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Dr. Parsa Mohebi created a new tool to improve hair transplant efficiency and reduce follicle damage.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Trichoscopy is a quick and reliable way to diagnose hair loss in women.

The topical treatment reduced hair loss and improved hair growth in patients with certain types of hair loss.

Light/laser therapy can effectively increase hair density in some types of alopecia, especially androgenic alopecia and alopecia areata.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

Many patients with hair loss had low iron and vitamin D levels, but thyroid issues were not common.

A patient experienced intense hair loss due to telogen effluvium after scalp contact dermatitis, but hair regrew completely within two months without further treatment.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Vitamin D deficiency is common in temporary hair loss, and stress is often a suspected cause.

Trichodynia is a painful scalp condition not directly linked to the amount or type of hair loss and may involve psychological factors, with treatments showing mixed results.

Researchers developed a new skin patch that delivers more finasteride into the skin, potentially improving treatment for hair loss and prostate issues.